Additional cost of hospital-acquired infection to the patient: a case study in Turkey

Hospital-acquired infections (HAIs) significantly increase both the patient's length of stay and the cost of disease. For this reason, HAIs are one of the most important problems that intensive study is devoted to in many countries around the world. The purpose of this study is to investigate how having a HAI prolongs the length of stay and adds unnecessary cost to the patient. The study compared two matched groups and suggested that a patient with a HAI spent an additional 23 days in the hospital compared with a patient not affected with a HAI. The results also showed that a patient with a HAI had to pay more in almost all cost categories compared with a non-infected patient. The additional cost for an infected patient was calculated as US$2026.70. As a result of HAIs, the hospital had additional, but avoidable, expenses of US$30,754 for 57 patients over a period of four months.

[1]  S. Metintaş,et al.  Prevalence and characteristics of nosocomial infections in a Turkish university hospital. , 2004, American journal of infection control.

[2]  M. Biffi,et al.  Three scenarios of clinical claim reimbursement for nosocomial infection: the good, the bad, and the ugly. , 2004, The Journal of hospital infection.

[3]  M. Askarian,et al.  National nosocomial infection surveillance system-based study in Iran: additional hospital stay attributable to nosocomial infections. , 2003, American journal of infection control.

[4]  Jennifer A. Roberts,et al.  An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients. , 2001, The Journal of hospital infection.

[5]  P. Beutels,et al.  Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. , 2001, The Journal of hospital infection.

[6]  A V Swan,et al.  The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. , 2001, The Journal of hospital infection.

[7]  M. Khan,et al.  Cost of Nosocomial Infection in Turkey: An Estimate Based on the University Hospital Data , 2001 .

[8]  M. Wilcox,et al.  The cost of hospital-acquired infection and the value of infection control. , 2000, The Journal of hospital infection.

[9]  M. Schumacher,et al.  Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events. , 2000, Journal of clinical epidemiology.

[10]  M. Wilcox,et al.  Financial burden of hospital-acquired Clostridium difficile infection. , 1996, The Journal of hospital infection.

[11]  O. Bilge,et al.  Estimation of increased hospital stay due to nosocomial infections in surgical patients: comparison of matched groups. , 1995, The Journal of hospital infection.

[12]  R. Coello,et al.  The cost of infection in surgical patients: a case-control study. , 1993, The Journal of hospital infection.

[13]  M. Schumacher,et al.  Added Hospital Stay Due to Wound Infections Following Cardiac Surgery , 1992, The Thoracic and cardiovascular surgeon.

[14]  C. Pannuti The Costs of Hospital Infection Control in a Developing Country , 1991, Infection Control & Hospital Epidemiology.

[15]  S. Raine Quality assurance and the role of infection control: a retrospective study of hospital-acquired infection in a District General Hospital based on three sites, 1978-1988. , 1991, The Journal of hospital infection.

[16]  E. Hedrick,et al.  Nosocomial Infection Rates as an Indicator of Quality , 1988, Medical care.

[17]  J. Reading,et al.  Risk factors for postoperative pneumonia. , 1981, The American journal of medicine.

[18]  R. Haley,et al.  Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. , 1981, The American journal of medicine.

[19]  R. Spengler,et al.  Hospital costs and mortality attributed to nosocomial bacteremias. , 1978, JAMA.

[20]  W. L. Moore Nosocomial infections: an overview. , 1974, American journal of hospital pharmacy.